India Launches HPV Vaccination Programme

Summary Notes: HPV Vaccination Launch in India

Public Health Initiative:

• On February 28, India launched a nationwide vaccination program for Human Papillomavirus (HPV) targeting adolescent girls, marking a significant commitment to eliminate cervical cancer.

Cervical Cancer Statistics:

• Cervical cancer is the fourth most common cancer among women globally, with approximately 660,000 new cases and 350,000 deaths annually.
• India's cervical cancer incidence is notable: over 78,000 new cases and around 43,000 deaths are reported each year.
• Cervical cancer is the second most common cancer among Indian women.

Risk Factors:

• Primary risk factors include early marriage, early sexual activity, multiple pregnancies, tobacco use, and poor genital hygiene.
• These factors are potentially modifiable through awareness programs, vaccination, and improved screening.

WHO Guidelines:

• The World Health Organization (WHO) has identified cervical cancer as the first cancer to aim for elimination globally, with the target of reducing its incidence to fewer than 4 new cases per 100,000 women annually.
• The WHO's "90–70–90" strategy:
  • 90% of girls vaccinated by age 15.
  • 70% of women screened by age 30.
  • 90% of women with disease treated successfully.

Vaccination Program Details:

• HPV vaccination has a strong safety record, predominantly causing mild side effects.
• The vaccine has been in use for over 20 years and has undergone extensive safety evaluations.
• Studies indicate that even a single dose of the HPV vaccine provides long-term protection against cervical cancer.

Global Implementation:

• Over 140 countries have implemented HPV vaccination programs.
• Evidence supports that improved awareness and vaccination can notably decrease cervical cancer rates.

Urban vs. Rural Disparity:

• Cervical cancer control progress has been uneven; urban areas show some decline due to better hygiene, while rural areas remain underserved.

Challenges Ahead:

• Past experiences from other nations indicate that without consistent vaccination coverage, cervical cancer cases can resurge.
• Sustainable efforts are required to ensure widespread vaccination to prevent the resurgence of cervical cancer.

Implications:

• The HPV vaccination initiative, combined with enhanced screening and treatment access, is crucial for reducing cervical cancer incidence in India. It is both a scientific and ethical imperative to improve public health outcomes for women.

Conclusion:

The HPV vaccination program launched in India aims to significantly address the burden of cervical cancer through prevention and awareness, aligning with global health strategies to eliminate this disease.